Neurocrine Biosciences Inc vs Old Dominion Freight Line Inc — how do they compare? Neurocrine Biosciences Inc trades at $143.97 (market cap $14.36B), while Old Dominion Freight Line Inc trades at $181.97 (market cap $37.68B). The key difference: Old Dominion Freight Line Inc is far larger — about 2.6× Neurocrine Biosciences Inc's market cap, and Old Dominion Freight Line Inc pays a 0.64% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Neurocrine Biosciences Inc for 23 Days and Old Dominion Freight Line Inc for 76 Days on average.
| NBIX | ODFL | |
|---|---|---|
Market Cap | $14.36B | $37.68B |
Volume | 1,237,180 | 1,550,104 |
Sector | Health | Industrials |
52-Week High | $185.50 | $248.73 |
52-Week Low | $123.10 | $126.29 |
Typical Hold Time | 23 Days | 76 Days |
Enterprise Value | $14.37B | $37.42B |
Dividend Yield | — | 0.64% |
Signals from Pluang's Aura AI — not financial advice
Neurocrine Biosciences (NBIX) trades at $142.44, down 0.72% with bearish technical signals but strong fundamentals including three consecutive quarterly EPS beats. The company shows robust profitability with 20.91% net margin and 22.09% ROE, supported by growing revenue from $2.9B to $3.4B projected. Recent news highlights pipeline development and conference participation.
Wall Street maintains strong bullish sentiment with 86% buy ratings and $204.18 consensus target, representing 43% upside. Key risks include INGREZZA pricing pressure in 2029 and execution challenges as the company diversifies beyond its main product. The stock offers growth potential but faces near-term technical headwinds.
Old Dominion Freight Line (ODFL) trades at $181.97, up 3.62% today, showing strong momentum after recent earnings beats. The stock faces a bearish technical signal despite positive fundamental metrics including a 19.44% net income margin and consistent earnings outperformance. Recent news highlights a 4.9% general rate increase effective October 5, 2026, aimed at offsetting operating costs while supporting service network investments. Analyst consensus remains mixed with a $230.93 price target suggesting 27% upside potential from current levels.
ODFL presents a compelling growth story with superior profitability metrics and strategic pricing power, though elevated valuation ratios (P/E 34.95) warrant caution. The company's pristine balance sheet with minimal debt and strong cash flow generation supports long-term stability. Key risks include freight market cyclicality and competitive pressures in the trucking industry. Wall Street sentiment leans cautious with 55.56% hold ratings, reflecting valuation concerns despite solid operational performance.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →Old Dominion Freight Line is the fourth-largest less-than-truckload carrier in the United States, with more than 240 service centers and 9,200-plus tractors. OD is by far one of the most disciplined and efficient providers in the trucking industry, and its profitability and capital returns stand head and shoulders above its peers. Strategic initiatives revolve around increasing network density through market share gains and maintaining industry-leading service via consistent infrastructure investment.
Read more on ODFL →